Wuhan Desheng Biochemical Technology Co., Ltd

products

Home /

products

AR Grade Blood Collection Tube Additives Potassium Oxalate Monohydrate Anticoagulant

Name: AR Grade Blood Collection Tube Additives Potassium Oxalate Monohydrate Anticoagulant
Brand: DESHENG
SKU: DS-CP009
Rating: 4.8 (196 reviews)

Product Details

Place of Origin: EZHOU, CHINA

Brand Name: DESHENG

Certification: ISO9001:2008

Model Number: DS-CP009

Payment & Shipping Terms

Minimum Order Quantity: 500g

Price: Negotiable

Packaging Details: Plastic bottle/Ctn Box

Delivery Time: 5-8 days

Payment Terms: L/C, D/A, D/P, T/T, Western Union, MoneyGram

Supply Ability: 10000kg/Month

Get Best Price

Contact Now

Specifications

Description

Specifications

High Light: 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    AR Grade Blood Collection Tube Additives, Potassium Oxalate Blood Collection Tube Additives, Potassium Oxalate Monohydrate Anticoagulant
                                                      

Name:	Potassium Oxalate	Appearance:	White Crystalline Powder
Purity:	≥99%	PH:	7.8
Category:	Blood Anticoagulant	Application:	Hematopath Analysis
Industry:	Medical & Healthy	Usage:	Vacuum Additives

Name:	Potassium Oxalate
Appearance:	White Crystalline Powder
Purity:	≥99%
PH:	7.8
Category:	Blood Anticoagulant
Application:	Hematopath Analysis
Industry:	Medical & Healthy
Usage:	Vacuum Additives

Description

AR Grade Blood Collection Tube Additives Potassium Oxalate Monohydrate Anticoagulant

AR Grade Potassium Oxalate Monohydrate Anticoagulant For Blood Collection Tube Vacuums

potassium oxalate monohydrate, potassium oxalate hydrate, oxalic acid potassium salt, ethanedioic acid, dipotassium salt, monohydrate, dipotassium oxalate hydrate, dipotassium hydrate oxalate, acmc-1bcm6, ksc495a4h, dipotassium oxalate monohydrate, dipotassium ethanedioate hydrate Show More

Quantity: 100g

Density: 2.13g/mL

Packaging: Lab Grade

Color: White

Assay Percent Range: >99%

Linear Formula: K 2 C 2 O 4 ·H 2 O

Potassium oxalate is a strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.

[product name] potassium oxalate monohydrate (C2K2O4·H2O)

Potassium Oxalate Anticoagulant Blood Collection Tube Additives Crystalline Powder 0

Potassium Oxalate Monohydrate Properties (Theoretical)

Compound Formula C2H2K2O5
Molecular Weight 184.24
Appearance White Powder
Melting Point 310 °C (590 °F)
Boiling Point N/A
Density 2.13g/cm3
Solubility in H2O N/A
Exact Mass 183.917637
Monoisotopic Mass 183.917637

Potassium Oxalate Monohydrate Health & Safety Information

Signal Word Warning
Hazard Statements H302-H312
Hazard Codes Xn
Risk Codes 21/22
Safety Statements 24/25
RTECS Number RO2885000
Transport Information UN 2928 6.1/PG 1
WGK Germany 1

[Molecular weight] 184.24

[Properties] Colorless crystal or white crystalline powder. It is tasteless and easy to weather in dry air. Dissolved in 3 parts of water, slightly soluble in ethanol. Crystal water is lost when heated to about 160 °C.

Potassium Oxalate Anticoagulant Blood Collection Tube Additives Crystalline Powder 1

[Executive standard] GB/T695-1994 (national standard)

[Use] Anticoagulant, used in combination with sodium fluoride, for blood glucose testing. (One-time use of vacuum blood collection tube additives).

【Package】 500g/bottle

Potassium Oxalate Anticoagulant Blood Collection Tube Additives Crystalline Powder 2

[Usage and Dosage]

The concentration should be 1 mg-3 mg (0.003934 mol/L-0.0111 mol/L) of potassium oxalate monohydrate per ml of blood.

Sodium fluoride 2 mg-4 mg (0.0476 mol/L-0.0952 mol/L).

The recommended dosage is: sodium fluoride (2.5-3mg/mL blood) / potassium oxalate (2.0mg/mL blood)

Appearance:	White Or Colorless Crystal Powder	Physical Property:	Odorless
Soublity:	H2O 25℃ 50g/L	Package:	500g/bottle
Specification:	500g/bottle	Molecular Weight:	184.24

[additive code: NFX]

[Storage] Sealed and moisture-proof.

[Validity Period] three years

AR Grade Blood Collection Tube Additives Potassium Oxalate Monohydrate Anticoagulant 3

SAFETY DATA SHEET

according to Regulation (EC) No. 1907/2006

Revision Date 04.11.2013

Version 11.9

Page 1 of 9

1. Identification of the substance/mixture and of the company/undertaking

1.1 Product identifier

Catalogue No. 105073

Product name di-Potassium oxalate monohydrate for analysis EMSURE® ACS

REACH Registration Number A registration number is not available for this substance as the

substance or its use are exempted from registration according

to Article 2 REACH Regulation (EC) No 1907/2006, the annual

tonnage does not require a registration or the registration is

envisaged for a later registration deadline.

1.2 Relevant identified uses of the substance or mixture and uses advised against

Identified uses Reagent for analysis

Disposable vacuum blood added reagents

1.3 Details of the supplier of the safety data sheet

Company: Hubei New Desheng Materials Technology Co., Ltd

Address: 8-2-2, Union Technology Area C, Gedian Development Zone, Ezhou City, Hubei,

China

Responsible Department e-mail: rockydai@whdschem.com

1.4 Emergency telephone

Telephone Number: 0086-711-3702650

Fax Number: 0086-711-3704589

E-mail: info@whdschem.com

2. Hazards identification

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008)

Acute toxicity, Category 4, Dermal, H312

Acute toxicity, Category 4, Oral, H302

For the full text of the H-Statements mentioned in this Section, see Section 16.

Classification (67/548/EEC or 1999/45/EC)

Xn; R21/22

For the full text of the R-phrases mentioned in this Section, see Section 16.

2.2 Label elements

Labelling (REGULATION (EC) No 1272/2008)

Hazard pictograms

Signal word

德晟Warning

Hazard statements

H302 + H312 Harmful if swallowed or in contact with skin.

Precautionary statements

SAFETY DATA SHEET

Page 2 of 9

according to Regulation (EC) No. 1907/2006

Catalogue No. 105073

Product name Di-Potassium oxalate monohydrate for analysis EMSURE® ACS

P302 + P352 IF ON SKIN: Wash with plenty of soap and water.

Reduced labelling (≤125 ml)

Hazard pictograms

Signal word

Warning

Index-No. 607-007-00-3

Labelling (67/548/EEC or 1999/45/EC)

Symbol(s) Xn Harmful

R-phrase(s) 21/22 Harmful in contact with skin and if swallowed.

S-phrase(s) 24/25 Avoid contact with skin and eyes.

EC-No. 209-506-8 EC Label

Reduced labelling (≤125 ml)

Symbol(s) Xn Harmful

R-phrase(s) 21/22 Harmful in contact with skin and if swallowed.

2.3 Other hazards

None known.

3. Composition/information on ingredients

Formula K2C2O4 * H2O C2K2O4 * H2O (Hill)

CAS-No. 6487-48-5

Index-No. 607-007-00-3

EC-No. 209-506-8

Molar mass 184,24 g/mol

4. First aid measures

4.1 Description of first aid measures

After inhalation: fresh air.

After skin contact: wash off with plenty of water. Remove contaminated clothing. Get

medical

attention.

After eye contact: rinse out with plenty of water.

After swallowing: immediately make victim drink water (two glasses at most). Consult

aphysician.4.2 Most important symptoms and effects, both acute and delayed

irritant effects

The following applies to oxalates in general: nausea and vomiting after swallowing.

Mucosal

SAFETY DATA SHEET

Page 3 of 9

according to Regulation (EC) No. 1907/2006

Catalogue No. 105073

Product name Di-Potassium oxalate monohydrate for analysis EMSURE® ACS

irritations, coughing, and dyspnoea after inhalation. Systemic effect: drop in the blood

calcium

level, toxic effect on kidneys, cardiovascular disorders.

4.3 Indication of immediate medical attention and special treatment needed

No information available.

5. Fire-fighting measures

5.1 Extinguishing media

Suitable extinguishing media

Use extinguishing measures that are appropriate to local circumstances and the

surrounding

environment.

Unsuitable extinguishing media

For this substance/mixture no limitations of extinguishing agents are given.

5.2 Special hazards arising from the substance or mixture

Not combustible.

Ambient fire may liberate hazardous vapours.

5.3 Advice for firefighters

Special protective equipment for fire-fighters

Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by

keeping a safe distance or by wearing suitable protective clothing.

Further information

Prevent fire extinguishing water from contaminating surface water or the ground water

system.

6. Accidental release measures

6.1 Personal precautions, protective equipment and emergency procedures

Advice for non-emergency personnel: Avoid substance contact. Avoid inhalation of dusts.

Ensure

adequate ventilation. Evacuate the danger area, observe emergency procedures, consult an

expert.

Advice for emergency responders: Protective equipment see section 8.

6.2 Environmental precautions

Do not empty into drains.

6.3 Methods and materials for containment and cleaning up

Cover drains. Collect, bind, and pump off spills.

Observe possible material restrictions (see sections 7.2 and 10.5).Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.

6.4 Reference to other sections

Indications about waste treatment see section 13.

7. Handling and storage

SAFETY DATA SHEET

Page 4 of 9

according to Regulation (EC) No. 1907/2006

Catalogue No. 105073

Product name Di-Potassium oxalate monohydrate for analysis EMSURE® ACS

7.1 Precautions for safe handling

Observe label precautions.

7.2 Conditions for safe storage, including any incompatibilities

Tightly closed. Dry.

Storage temperature: no restrictions.

7.3 Specific end uses

Apart from the uses mentioned in section 1.2 no other specific uses are stipulated.

8. Exposure controls/personal protection

8.1 Control parameters

8.2 Exposure controls

Engineering measures

Technical measures and appropriate working operations should be given priority over the

use of

personal protective equipment.

See section 7.1.

Individual protection measures

Protective clothing needs to be selected specifically for the workplace, depending on

concentrations and quantities of the hazardous substances handled. The chemical

resistance of

the protective equipment should be enquired at the respective supplier.

Hygiene measures

Immediately change contaminated clothing. Apply preventive skin protection. Wash hands

and

face after working with substance.

Eye/face protection

Safety glasses

Hand protection

full contact:

Glove material: Nitrile rubber

Glove thickness: 0,11 mm

Break through time: > 480 min

splash contact:

Glove material: Nitrile rubber

Glove thickness: 0,11 mm

Break through time: > 480 mi

Tags:

Please send us your request and we will reply to you as soon as possible.

Send

Blood Collection Tube Additives

Chemiluminescent Reagent

Good Buffer Solutions

Tromethamine

Trinder Reagent

Biological Buffer

Enzyme Preparation

Antigen Antibody

Serum Separator Gel

Anticoagulant For Blood Collection

Blood Clot Activator

Blood Coagulant Powder

Intermediate

AR Grade Blood Collection Tube Additives Potassium Oxalate Monohydrate Anticoagulant